Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Gullans Steven R. Ph.D. Create: Alert

All | News | Filings
Date FiledTypeDescription
05/17/2023 4 Gullans Steven R. Ph.D. (Director) has filed a Form 4 on iSpecimen Inc.
Txns: Granted 125 shares @ $0
02/10/2023 5 Form 5 - Annual statement of changes in beneficial ownership of securities:
01/13/2023 4 Gullans Steven R. Ph.D. (Director) has filed a Form 4 on iSpecimen Inc.
Txns: Granted 10,000 options @ $1.41, valued at $14.1k
02/14/2022 5 Gullans Steven R. Ph.D. (Director) has filed a Form 5 on iSpecimen Inc.
06/17/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
01/15/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2019 4 Gullans Steven R. Ph.D. (President & CEO) has filed a Form 4 on Gemphire Therapeutics Inc.
Txns: Granted 300,000 shares @ $0
05/24/2018 4 Gullans Steven R. Ph.D. (President & CEO) has filed a Form 4 on Gemphire Therapeutics Inc.
Txns: Granted 50,000 options to buy @ $5.56, valued at $278k
02/12/2018 4 Gullans Steven R. Ph.D. (Interim President & CEO) has filed a Form 4 on Gemphire Therapeutics Inc.
Txns: Bought 71,429 shares @ $7, valued at $500k
01/30/2018 4 Gullans Steven R. Ph.D. (Interim President & CEO) has filed a Form 4 on Gemphire Therapeutics Inc.
Txns: Granted 60,000 options to buy @ $10.44, valued at $626.4k
07/06/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
06/28/2017 3 Form 3 - Initial statement of beneficial ownership of securities
05/31/2017 4 Gullans Steven R. Ph.D. (Interim President & CEO) has filed a Form 4 on Gemphire Therapeutics Inc.
Txns: Granted 60,000 options to buy @ $10.26, valued at $615.6k
03/14/2017 4 Gullans Steven R. Ph.D. (Director) has filed a Form 4 on Gemphire Therapeutics Inc.
08/12/2016 4 Gullans Steven R. Ph.D. (Director) has filed a Form 4 on Gemphire Therapeutics Inc.
08/08/2016 4 Gullans Steven R. Ph.D. (Director) has filed a Form 4 on Gemphire Therapeutics Inc.
08/04/2016 3 Gullans Steven R. Ph.D. (Director) has filed a Form 3 on Gemphire Therapeutics Inc.
06/16/2014 4 Form 4 - Statement of changes in beneficial ownership of securities
05/21/2014 4 Gullans Steven R. Ph.D. (Director) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC
Txns: Bought 25,000 shares @ $9.2391, valued at $231k
03/27/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
03/19/2013 3 Gullans Steven R. Ph.D. (10% Owner) has filed a Form 3 on TETRAPHASE PHARMACEUTICALS INC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy